Guideline Central Blog

November marks Lung Cancer Awareness Month and November 11 is dedicated to National Lung Cancer Awareness Day. Lung cancer is the leading cause of cancer death among men and women in the United States, accounting for more deaths than colon cancer, breast cancer and prostate cancer combined.

There are two main forms of lung cancer – small cell lung cancer and non-small cell lung cancer. Non-small cell lung cancer is the more common form of the disease. The most common subtypes of non-small cell lung cancer are squamous cell carcinoma, which begins in the thin, flat squamous cells; large cell carcinoma; and adenocarcinoma, which begins in the cells that line the alveoli, the tiny sacs within the lungs. Other less common types of non-small cell lung cancer are: pleomorphic, carcinoid tumor, salivary gland carcinoma, and unclassified carcinoma.

For Lung Cancer Awareness Month 2023, we’ve compiled a list of the all the latest lung cancer related clinical practice guidelines up to date to quickly reference when needed.

Lung Cancer Screening & Monitoring Guidelines:

• Lung Cancer Screening
  • National Comprehensive Cancer Network (NCCN) – Published October 2023

• Lung Cancer Surveillance After Definitive Curative-Intent Therapy
  • American Society of Clinical Oncology (ASCO) – Published December 12, 2019

• Screening For Lung Cancer
  • American College of Chest Physicians (CHEST) – Published July 13, 2021

Non-Small Cell Lung Cancer Guidelines:

• Management of Stage III Non-Small Cell Lung Cancer
  • American Society of Clinical Oncology (ASCO) – Published July 20, 2023

• Stage IV Non-Small Cell Lung Cancer without Driver Alterations
  • American Society of Clinical Oncology (ASCO) – Published July 11, 2023

• Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations
  • American Society of Clinical Oncology (ASCO) – Published July 11, 2023

• Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers
  • American Society of Clinical Oncology (ASCO) – Published February 17, 2022

• Non-Small Cell Lung Cancer
  • National Comprehensive Cancer Network (NCCN) – Published October 2023

• Treatment of Oligometastatic Non-Small Cell Lung Cancer
  • American Society for Radiation Oncology (ASTRO) – Published April 25, 2023

• Palliative Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)
  • American Society for Radiation Oncology (ASTRO) – Published August 1, 2018

• Stereotactic Body Radiation Therapy For Early-Stage Non-Small Cell Lung Cancer
  • American Society for Radiation Oncology (ASTRO) – Published October 1, 2017

• Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease of the Lungs
  • Society of Interventional Radiology (SIR) – Published August 1, 2021

• Staging and Multidisciplinary Management of Patients with Early-Stage Non–Small Cell Lung Cancer
  • American Association for Thoracic Surgery (AATS) – Published June 10, 2023

Small Cell Lung Cancer Guidelines:

• Systemic Therapy for Small Cell Lung Cancer
  • American Society of Clinical Oncology (ASCO) – Published October 11, 2023

• Small Cell Lung Cancer
  • National Comprehensive Cancer Network (NCCN) – Published September 2023

• Radiation Therapy for Small Cell Lung Cancer
  • American Society for Radiation Oncology (ASTRO) – Published March 1, 2020

Other Lung Cancer Guidelines:

• Immunotherapy for the Treatment of Lung Cancer and Mesothelioma
  • Society for Immunotherapy of Cancer (SIC) – Published May 31, 2022

• Symptomatic Treatment of Cough Among Adult Patients With Lung Cancer
  • American College of Chest Physicians (CHEST) – Published April 1, 2017

We expect new and updated clinical guidelines on lung cancer from American Society of Clinical Oncology (ASCO), National Comprehensive Cancer Network (NCCN) and many other reputable medical organizations in the coming year.